OM Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
33.6M
+6.2%
31.6M
+13.5%
27.9M
-3.5%
28.9M
-1.9%
29.4M
Cost of Revenue
19.9M
+8.6%
18.4M
+16.4%
15.8M
-5.3%
16.6M
-6.7%
17.8M
Gross Profit
13.7M
+2.9%
13.3M
+9.8%
12.1M
-1.1%
12.2M
+5.5%
11.6M
Operating Expenses
25.9M
-10.4%
29.0M
-0.2%
29.0M
-2.8%
29.9M
+9.0%
27.4M
R&D
5.9M
+8.2%
5.5M
-3.0%
5.6M
+11.1%
5.1M
-6.0%
5.4M
SG&A
20.0M
-14.7%
23.5M
+0.5%
23.4M
-5.7%
24.8M
+12.6%
22.0M
Operating Income
-12269000
+21.7%
-15676000
+7.3%
-16919000
+4.0%
-17629000
-11.5%
-15813000
EBITDA
-11603000
+22.9%
-15049000
+6.7%
-16124000
+3.7%
-16748000
-13.1%
-14802000
Net Income
-14686000
+18.3%
-17984000
+5.2%
-18978000
+2.6%
-19491000
-9.3%
-17838000
EPS (Basic)
$-0.78
+19.6%
$-0.97
+5.8%
$-1.03
+3.7%
$-1.07
-7.0%
$-1.00
EPS (Diluted)
$-0.78
+19.6%
$-0.97
+5.8%
$-1.03
+3.7%
$-1.07
-7.0%
$-1.00
Shares (Diluted)
18.8M
+1.1%
18.6M
+1.3%
18.4M
+0.5%
18.3M
+2.8%
17.8M
Outset Medical (OM) — Financials